Difference between revisions of "Testingnew move2"
Jump to navigation
Jump to search
[unchecked revision] | [unchecked revision] |
Bailey.Glen (talk | contribs) |
Bailey.Glen (talk | contribs) |
||
(15 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
− | |||
==Myeloid proliferations and neoplasms ([[Myeloid proliferations and neoplasms|Overview Page Link]])== | ==Myeloid proliferations and neoplasms ([[Myeloid proliferations and neoplasms|Overview Page Link]])== | ||
− | + | ||
+ | '''Myeloid precursor lesions''' | ||
''Clonal Haematopoiesis'' | ''Clonal Haematopoiesis'' | ||
- [[Clonal haematopoiesis]] | - [[Clonal haematopoiesis]] | ||
- [[Clonal cytopenias of undetermined significance]] | - [[Clonal cytopenias of undetermined significance]] | ||
− | + | ||
+ | '''Myeloproliferative neoplasms | ||
''Myeloproliferative neoplasms'' | ''Myeloproliferative neoplasms'' | ||
- [[Chronic myeloid leukaemia]] | - [[Chronic myeloid leukaemia]] | ||
Line 15: | Line 16: | ||
- [[Juvenile myelomonocytic leukaemia]] | - [[Juvenile myelomonocytic leukaemia]] | ||
- [[Myeloproliferative neoplasm, NOS]] | - [[Myeloproliferative neoplasm, NOS]] | ||
− | + | ||
+ | '''Mastocytosis''' | ||
- [[Cutaneous mastocytosis]] | - [[Cutaneous mastocytosis]] | ||
- [[Systemic mastocytosis]] | - [[Systemic mastocytosis]] | ||
- [[Mast cell sarcoma]] | - [[Mast cell sarcoma]] | ||
− | + | ||
+ | '''Myelodysplastic neoplasms''' | ||
''Myelodysplastic neoplasms, with defining genetic abnormalities'' | ''Myelodysplastic neoplasms, with defining genetic abnormalities'' | ||
- [[Myelodysplastic neoplasm with low blasts and 5q deletion]] | - [[Myelodysplastic neoplasm with low blasts and 5q deletion]] | ||
Line 31: | Line 34: | ||
- [[Childhood myelodysplastic neoplasm with low blasts]] | - [[Childhood myelodysplastic neoplasm with low blasts]] | ||
- [[Childhood myelodysplastic neoplasm with increased blasts]] | - [[Childhood myelodysplastic neoplasm with increased blasts]] | ||
− | + | ||
+ | '''Myelodysplastic/myeloproliferative neoplasms''' | ||
- [[Chronic myelomonocytic leukaemia]] | - [[Chronic myelomonocytic leukaemia]] | ||
- [[Myelodysplastic/myeloproliferative neoplasm with neutrophilia]] | - [[Myelodysplastic/myeloproliferative neoplasm with neutrophilia]] | ||
- [[Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis]] | - [[Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis]] | ||
- [[Myelodysplastic/myeloproliferative neoplasm, NOS]] | - [[Myelodysplastic/myeloproliferative neoplasm, NOS]] | ||
− | + | ||
+ | '''Acute myeloid leukaemia''' | ||
''Acute myeloid leukaemia with defining genetic abnormalities'' | ''Acute myeloid leukaemia with defining genetic abnormalities'' | ||
- [[Acute promyelocytic leukaemia with PML::RARA fusion]] | - [[Acute promyelocytic leukaemia with PML::RARA fusion]] | ||
Line 62: | Line 67: | ||
''Myeloid sarcoma'' | ''Myeloid sarcoma'' | ||
- [[Myeloid sarcoma]] | - [[Myeloid sarcoma]] | ||
− | + | ||
+ | '''Myeloid neoplasms, secondary''' | ||
''Myeloid neoplasms and proliferations associated with antecedent or predisposing conditions'' | ''Myeloid neoplasms and proliferations associated with antecedent or predisposing conditions'' | ||
- [[Myeloid neoplasm post cytotoxic therapy]] | - [[Myeloid neoplasm post cytotoxic therapy]] | ||
- [[Myeloid neoplasms associated with germline predisposition]] | - [[Myeloid neoplasms associated with germline predisposition]] | ||
- [[Myeloid proliferations associated with Down syndrome]] | - [[Myeloid proliferations associated with Down syndrome]] | ||
− | + | ||
+ | '''Myeloid/lymphoid neoplasms''' | ||
''Myeloid/lymphoid neoplasms with eosinophilia and defining gene rearrangement'' | ''Myeloid/lymphoid neoplasms with eosinophilia and defining gene rearrangement'' | ||
- [[Myeloid/lymphoid neoplasm with PDGFRA rearrangement]] | - [[Myeloid/lymphoid neoplasm with PDGFRA rearrangement]] | ||
Line 76: | Line 83: | ||
- [[Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion]] | - [[Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion]] | ||
- [[Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes]] | - [[Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes]] | ||
− | + | ||
+ | '''Acute leukaemias of mixed or ambiguous lineage''' | ||
''Acute leukaemia of ambiguous lineage with defining genetic abnormalities'' | ''Acute leukaemia of ambiguous lineage with defining genetic abnormalities'' | ||
- [[Mixed-phenotype acute leukaemia with BCR::ABL1 fusion]] | - [[Mixed-phenotype acute leukaemia with BCR::ABL1 fusion]] | ||
Line 88: | Line 96: | ||
- [[Acute undifferentiated leukaemia]] | - [[Acute undifferentiated leukaemia]] | ||
==Histiocytic/Dendritic cell neoplasms ([[Histiocytic/Dendritic cell neoplasms|Overview Page Link]])== | ==Histiocytic/Dendritic cell neoplasms ([[Histiocytic/Dendritic cell neoplasms|Overview Page Link]])== | ||
− | + | ||
+ | '''Plasmacytoid dendritic cell neoplasms''' | ||
''Plasmacytoid dendritic cell neoplasms'' | ''Plasmacytoid dendritic cell neoplasms'' | ||
- [[Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm]] | - [[Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm]] | ||
- [[Blastic plasmacytoid dendritic cell neoplasm]] | - [[Blastic plasmacytoid dendritic cell neoplasm]] | ||
− | + | ||
+ | '''Langerhans cell and other dendritic cell neoplasms''' | ||
''Langerhans cells neoplasms'' | ''Langerhans cells neoplasms'' | ||
- [[Langerhans cell histiocytosis]] | - [[Langerhans cell histiocytosis]] | ||
Line 99: | Line 109: | ||
- [[Indeterminate dendritic cell tumour]] | - [[Indeterminate dendritic cell tumour]] | ||
- [[Interdigitating dendritic cell sarcoma]] | - [[Interdigitating dendritic cell sarcoma]] | ||
− | + | ||
+ | '''Histiocyte/macrophage neoplasms''' | ||
''Histiocytic neoplasms'' | ''Histiocytic neoplasms'' | ||
- [[Juvenile xanthogranuloma]] | - [[Juvenile xanthogranuloma]] | ||
Line 107: | Line 118: | ||
- [[Histiocytic sarcoma]] | - [[Histiocytic sarcoma]] | ||
==B-cell lymphoid proliferations and lymphomas ([[B-cell lymphoid proliferations and lymphomas|Overview Page Link]])== | ==B-cell lymphoid proliferations and lymphomas ([[B-cell lymphoid proliferations and lymphomas|Overview Page Link]])== | ||
− | + | ||
+ | '''Tumour like lesions with B-cell predominance''' | ||
- [[Reactive B-cell rich lymphoid proliferations that can mimic lymphoma]] | - [[Reactive B-cell rich lymphoid proliferations that can mimic lymphoma]] | ||
- [[IgG4-related disease]] | - [[IgG4-related disease]] | ||
Line 113: | Line 125: | ||
- [[Idiopathic multicentric Castleman disease]] | - [[Idiopathic multicentric Castleman disease]] | ||
- [[KSHV/HHV8-associated multicentric Castleman disease]] | - [[KSHV/HHV8-associated multicentric Castleman disease]] | ||
− | + | ||
+ | '''Precursor B-cell neoplasms''' | ||
''B-lymphoblastic leukaemias/lymphomas'' | ''B-lymphoblastic leukaemias/lymphomas'' | ||
- [[B-lymphoblastic leukaemia/lymphoma]] | - [[B-lymphoblastic leukaemia/lymphoma]] | ||
Line 129: | Line 142: | ||
- [[B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations]] | - [[B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations]] | ||
- [[B-lymphoblastic leukaemia/lymphoma, NOS]] | - [[B-lymphoblastic leukaemia/lymphoma, NOS]] | ||
− | + | ||
+ | '''Mature B-cell neoplasms''' | ||
''Pre-neoplastic and neoplastic small lymphocytic proliferations '' | ''Pre-neoplastic and neoplastic small lymphocytic proliferations '' | ||
- [[Monoclonal B-cell lymphocytosis]] | - [[Monoclonal B-cell lymphocytosis]] | ||
Line 189: | Line 203: | ||
- [[Lymphomas arising in immune deficiency / dysregulation ]] | - [[Lymphomas arising in immune deficiency / dysregulation ]] | ||
- [[Inborn error of immunity-associated lymphoid proliferations and lymphomas]] | - [[Inborn error of immunity-associated lymphoid proliferations and lymphomas]] | ||
− | + | ||
+ | '''Hodgkin lymphoma''' | ||
- [[Classic Hodgkin lymphoma ]] | - [[Classic Hodgkin lymphoma ]] | ||
- [[Nodular lymphocyte predominant Hodgkin lymphoma]] | - [[Nodular lymphocyte predominant Hodgkin lymphoma]] | ||
− | + | ||
+ | '''Plasma cell neoplasms and other diseases with paraproteins''' | ||
''Monoclonal gammopathies'' | ''Monoclonal gammopathies'' | ||
- [[Cold agglutinin disease ]] | - [[Cold agglutinin disease ]] | ||
Line 206: | Line 222: | ||
- [[Alpha heavy chain disease]] | - [[Alpha heavy chain disease]] | ||
''Plasma cell neoplasms'' | ''Plasma cell neoplasms'' | ||
− | - [[Plasmacytoma]] | + | - [[HAEM5:Plasmacytoma]] |
- [[Plasma cell myeloma / multiple myeloma]] | - [[Plasma cell myeloma / multiple myeloma]] | ||
- [[Plasma cell neoplasms with associated paraneoplastic syndrome]] | - [[Plasma cell neoplasms with associated paraneoplastic syndrome]] | ||
==T-cell and NK-cell lymphoid proliferations and lymphomas ([[T-cell and NK-cell lymphoid proliferations and lymphomas |Overview Page Link]])== | ==T-cell and NK-cell lymphoid proliferations and lymphomas ([[T-cell and NK-cell lymphoid proliferations and lymphomas |Overview Page Link]])== | ||
− | + | ||
+ | '''Tumour-like lesions with T-cell predominance''' | ||
- [[Kikuchi-Fujimoto disease]] | - [[Kikuchi-Fujimoto disease]] | ||
- [[Autoimmune lymphoproliferative syndrome]] | - [[Autoimmune lymphoproliferative syndrome]] | ||
- [[Indolent T-lymphoblastic proliferation]] | - [[Indolent T-lymphoblastic proliferation]] | ||
− | + | ||
+ | '''Precursor T-cell neoplasms''' | ||
''T-lymphoblastic leukaemia / lymphoma'' | ''T-lymphoblastic leukaemia / lymphoma'' | ||
- [[T-lymphoblastic leukaemia / lymphoma, NOS]] | - [[T-lymphoblastic leukaemia / lymphoma, NOS]] | ||
- [[Early T-precursor lymphoblastic leukaemia / lymphoma ]] | - [[Early T-precursor lymphoblastic leukaemia / lymphoma ]] | ||
− | + | ||
+ | '''Mature T-cell and NK-cell neoplasms''' | ||
''Mature T-cell and NK-cell leukaemias'' | ''Mature T-cell and NK-cell leukaemias'' | ||
- [[T-prolymphocytic leukaemia]] | - [[T-prolymphocytic leukaemia]] | ||
Line 263: | Line 282: | ||
- [[Systemic EBV-positive T-cell lymphoma of childhood]] | - [[Systemic EBV-positive T-cell lymphoma of childhood]] | ||
==Stroma-derived neoplasms of lymphoid tissues ([[Stroma-derived neoplasms of lymphoid tissues|Overview Page Link]])== | ==Stroma-derived neoplasms of lymphoid tissues ([[Stroma-derived neoplasms of lymphoid tissues|Overview Page Link]])== | ||
− | + | ||
+ | '''Mesenchymal dendritic cell neoplasms''' | ||
''Follicular dendritic cell neoplasms'' | ''Follicular dendritic cell neoplasms'' | ||
- [[Follicular dendritic cell sarcoma]] | - [[Follicular dendritic cell sarcoma]] | ||
- [[EBV-positive inflammatory follicular dendritic cell sarcoma]] | - [[EBV-positive inflammatory follicular dendritic cell sarcoma]] | ||
- [[Fibroblastic reticular cell tumour]] | - [[Fibroblastic reticular cell tumour]] | ||
− | + | ||
+ | '''Myofibroblastic tumours''' | ||
''Myofibroblastic tumour'' | ''Myofibroblastic tumour'' | ||
- [[Intranodal palisaded myofibroblastoma]] | - [[Intranodal palisaded myofibroblastoma]] | ||
− | + | ||
+ | '''Spleen-specific vascular-stromal tumours''' | ||
''Splenic vascular-stromal tumours'' | ''Splenic vascular-stromal tumours'' | ||
- [[Littoral cell angioma]] | - [[Littoral cell angioma]] | ||
Line 280: | Line 302: | ||
- [[Bloom syndrome]] | - [[Bloom syndrome]] | ||
- [[Ataxia-telangiectasia syndrome]] | - [[Ataxia-telangiectasia syndrome]] | ||
− | - [[RASopathies] | + | - [[RASopathies]] |
Latest revision as of 15:03, 12 December 2023
Myeloid proliferations and neoplasms (Overview Page Link)
Myeloid precursor lesions Clonal Haematopoiesis - Clonal haematopoiesis - Clonal cytopenias of undetermined significance
Myeloproliferative neoplasms Myeloproliferative neoplasms - Chronic myeloid leukaemia - Chronic neutrophilic leukaemia - Chronic eosinophilic leukaemia - Polycythaemia vera - Essential thrombocythaemia - Primary myelofibrosis - Juvenile myelomonocytic leukaemia - Myeloproliferative neoplasm, NOS
Mastocytosis - Cutaneous mastocytosis - Systemic mastocytosis - Mast cell sarcoma
Myelodysplastic neoplasms Myelodysplastic neoplasms, with defining genetic abnormalities - Myelodysplastic neoplasm with low blasts and 5q deletion - Myelodysplastic neoplasm with low blasts and SF3B1 mutation - Myelodysplastic neoplasm with biallelic TP53 inactivation Myelodysplastic neoplasms, morphologically defined - Myelodysplastic neoplasm with low blasts - Myelodysplastic neoplasm, hypoplastic - Myelodysplastic neoplasm with increased blasts Myelodysplastic neoplasms of childhood - Childhood myelodysplastic neoplasm with low blasts - Childhood myelodysplastic neoplasm with increased blasts
Myelodysplastic/myeloproliferative neoplasms - Chronic myelomonocytic leukaemia - Myelodysplastic/myeloproliferative neoplasm with neutrophilia - Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis - Myelodysplastic/myeloproliferative neoplasm, NOS
Acute myeloid leukaemia Acute myeloid leukaemia with defining genetic abnormalities - Acute promyelocytic leukaemia with PML::RARA fusion - Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion - Acute myeloid leukaemia with CBFB::MYH11 fusion - Acute myeloid leukaemia with DEK::NUP214 fusion - Acute myeloid leukaemia with RBM15::MRTFA fusion - Acute myeloid leukaemia with BCR::ABL1 fusion - Acute myeloid leukaemia with KMT2A rearrangement - Acute myeloid leukaemia with MECOM rearrangement - Acute myeloid leukaemia with NUP98 rearrangement - Acute myeloid leukaemia with NPM1 mutation - Acute myeloid leukaemia with CEBPA mutation - Acute myeloid leukaemia, myelodysplasia-related - Acute myeloid leukaemia with other defined genetic alterations Acute myeloid leukaemia, defined by differentiation - Acute myeloid leukaemia with minimal differentiation - Acute myeloid leukaemia without maturation - Acute myeloid leukaemia with maturation - Acute basophilic leukaemia - Acute myelomonocytic leukaemia - Acute monocytic leukaemia - Acute erythroid leukaemia - Acute megakaryoblastic leukaemia Myeloid sarcoma - Myeloid sarcoma
Myeloid neoplasms, secondary Myeloid neoplasms and proliferations associated with antecedent or predisposing conditions - Myeloid neoplasm post cytotoxic therapy - Myeloid neoplasms associated with germline predisposition - Myeloid proliferations associated with Down syndrome
Myeloid/lymphoid neoplasms Myeloid/lymphoid neoplasms with eosinophilia and defining gene rearrangement - Myeloid/lymphoid neoplasm with PDGFRA rearrangement - Myeloid/lymphoid neoplasm with PDGFRB rearrangement - Myeloid/lymphoid neoplasm with FGFR1 rearrangement - Myeloid/lymphoid neoplasm with JAK2 rearrangement - Myeloid/lymphoid neoplasm with FLT3 rearrangement - Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion - Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes
Acute leukaemias of mixed or ambiguous lineage Acute leukaemia of ambiguous lineage with defining genetic abnormalities - Mixed-phenotype acute leukaemia with BCR::ABL1 fusion - Mixed-phenotype acute leukaemia with KMT2A rearrangement - Acute leukaemia of ambiguous lineage with other defined genetic alterations Acute leukaemia of ambiguous lineage, immunophenotypically defined - Mixed-phenotype acute leukaemia, B/myeloid - Mixed-phenotype acute leukaemia, T/myeloid - Mixed-phenotype acute leukaemia, rare types - Acute leukaemia of ambiguous lineage, NOS - Acute undifferentiated leukaemia
Histiocytic/Dendritic cell neoplasms (Overview Page Link)
Plasmacytoid dendritic cell neoplasms Plasmacytoid dendritic cell neoplasms - Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm - Blastic plasmacytoid dendritic cell neoplasm
Langerhans cell and other dendritic cell neoplasms Langerhans cells neoplasms - Langerhans cell histiocytosis - Langerhans cell sarcoma Other dendritic cell neoplasms - Indeterminate dendritic cell tumour - Interdigitating dendritic cell sarcoma
Histiocyte/macrophage neoplasms Histiocytic neoplasms - Juvenile xanthogranuloma - Erdheim-Chester disease - Rosai-Dorfman Disease - ALK-positive histiocytosis - Histiocytic sarcoma
B-cell lymphoid proliferations and lymphomas (Overview Page Link)
Tumour like lesions with B-cell predominance - Reactive B-cell rich lymphoid proliferations that can mimic lymphoma - IgG4-related disease - Unicentric Castleman disease - Idiopathic multicentric Castleman disease - KSHV/HHV8-associated multicentric Castleman disease
Precursor B-cell neoplasms B-lymphoblastic leukaemias/lymphomas - B-lymphoblastic leukaemia/lymphoma - B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy - B-lymphoblastic leukaemia/lymphoma with hypodiploidy - B-lymphoblastic leukaemia/lymphoma with iAMP21 - B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion - B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features - B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement - B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion - B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features - B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion - B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion - B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion - B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations - B-lymphoblastic leukaemia/lymphoma, NOS
Mature B-cell neoplasms Pre-neoplastic and neoplastic small lymphocytic proliferations - Monoclonal B-cell lymphocytosis - Chronic lymphocytic leukaemia/small lymphocytic lymphoma Splenic B-cell lymphomas and leukaemias - Hairy cell leukaemia - Splenic marginal zone lymphoma - Splenic diffuse red pulp small B-cell lymphoma - Splenic B-cell lymphoma/leukaemia with prominent nucleoli Lymphoplasmacytic lymphoma - Lymphoplasmacytic lymphoma Marginal zone lymphoma - Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue - Primary cutaneous marginal zone lymphoma - Nodal marginal zone lymphoma - Paediatric nodal marginal zone lymphoma Follicular lymphoma - In situ follicular B-cell neoplasm - Follicular lymphoma - Paediatric-type follicular lymphoma - Duodenal-type follicular lymphoma Cutaneous follicle centre lymphoma - Primary cutaneous follicle centre lymphoma Mantle cell lymphoma - In situ mantle cell neoplasm - Mantle cell lymphoma - Leukaemic non-nodal mantle cell lymphoma Transformations of indolent B-cell lymphomas - Transformations of indolent B-cell lymphomas Large B-cell lymphomas - Diffuse large B-cell lymphoma, NOS - T-cell/histiocyte-rich large B-cell lymphoma - Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL2 rearrangements - ALK-positive large B-cell lymphoma - Large B-cell lymphoma with IRF4 rearrangement - High grade B-cell lymphoma with 11q aberrations - Lymphomatoid granulomatosis - EBV-positive diffuse large B-cell lymphoma - Diffuse large B-cell lymphoma associated with chronic inflammation - Fibrin-associated large B-cell lymphoma - Fluid overload-associated large B-cell lymphoma - Plasmablastic lymphoma - Primary large B-cell lymphoma of immune-privileged sites - Primary cutaneous diffuse large B-cell lymphoma, leg type - Intravascular large B-cell lymphoma - Primary mediastinal large B-cell lymphoma - Mediastinal grey zone lymphoma - High-grade B-cell lymphoma, NOS Burkitt lymphoma - Burkitt lymphoma KSHV/HHV8-associated B-cell lymphoid proliferations and lymphomas - Primary effusion lymphoma - KSHV/HHV8-positive diffuse large B-cell lymphoma - KSHV/HHV8-positive germinotropic lymphoproliferative disorder Lymphoid proliferations and lymphomas associated with immune deficiency and dysregulation - Hyperplasias arising in immune deficiency/dysregulation - Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation - EBV-positive mucocutaneous ulcer - Lymphomas arising in immune deficiency / dysregulation - Inborn error of immunity-associated lymphoid proliferations and lymphomas
Hodgkin lymphoma - Classic Hodgkin lymphoma - Nodular lymphocyte predominant Hodgkin lymphoma
Plasma cell neoplasms and other diseases with paraproteins Monoclonal gammopathies - Cold agglutinin disease - IgM monoclonal gammopathy of undetermined significance - Non-IgM monoclonal gammopathy of undetermined significance - Monoclonal gammopathy of renal significance Diseases with monoclonal immunoglobulin deposition - Immunoglobulin-related (AL) amyloidosis - Monoclonal immunoglobulin deposition disease Heavy chain diseases - Mu heavy chain disease - Gamma heavy chain disease - Alpha heavy chain disease Plasma cell neoplasms - HAEM5:Plasmacytoma - Plasma cell myeloma / multiple myeloma - Plasma cell neoplasms with associated paraneoplastic syndrome
T-cell and NK-cell lymphoid proliferations and lymphomas (Overview Page Link)
Tumour-like lesions with T-cell predominance - Kikuchi-Fujimoto disease - Autoimmune lymphoproliferative syndrome - Indolent T-lymphoblastic proliferation
Precursor T-cell neoplasms T-lymphoblastic leukaemia / lymphoma - T-lymphoblastic leukaemia / lymphoma, NOS - Early T-precursor lymphoblastic leukaemia / lymphoma
Mature T-cell and NK-cell neoplasms Mature T-cell and NK-cell leukaemias - T-prolymphocytic leukaemia - T-large granular lymphocytic leukaemia - NK-large granular lymphocytic leukaemia - Adult T-cell leukaemia/lymphoma - Sezary syndrome - Aggressive NK-cell leukaemia Primary cutaneous T-cell lymphoid proliferations and lymphomas - Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder - Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder - Mycosis fungoides - Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis - Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma - Subcutaneous panniculitis-like T-cell lymphoma - Primary cutaneous gamma/delta T-cell lymphoma - Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma - Primary cutaneous peripheral T-cell lymphoma, NOS Intestinal T-cell and NK-cell lymphoid proliferations and lymphomas - Indolent T-cell lymphoma of the gastrointestinal tract - Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract - Enteropathy-associated T-cell lymphoma - Monomorphic epitheliotropic intestinal T-cell lymphoma - Intestinal T-cell lymphoma, NOS Hepatosplenic T-cell lymphoma - Hepatosplenic T-cell lymphoma Anaplastic large cell lymphoma - ALK-positive anaplastic large cell lymphoma - ALK-negative anaplastic large cell lymphoma - Breast implant-associated anaplastic large cell lymphoma Nodal T-follicular helper (TFH) cell lymphoma - Nodal TFH cell lymphoma, angioimmunoblastic-type - Nodal TFH cell lymphoma, follicular-type - Nodal TFH cell lymphoma, NOS Other peripheral T-cell lymphomas - Peripheral T-cell lymphoma, NOS EBV-positive NK-cell and T-cell lymphomas - EBV-positive nodal T- and NK-cell lymphoma - Extranodal NK/T-cell lymphoma EBV-positive T-cell and NK-cell lymphoid proliferations and lymphomas of childhood - Severe mosquito bite allergy - Hydroa vacciniforme lymphoproliferative disorder - Systemic chronic active EBV disease - Systemic EBV-positive T-cell lymphoma of childhood
Stroma-derived neoplasms of lymphoid tissues (Overview Page Link)
Mesenchymal dendritic cell neoplasms Follicular dendritic cell neoplasms - Follicular dendritic cell sarcoma - EBV-positive inflammatory follicular dendritic cell sarcoma - Fibroblastic reticular cell tumour
Myofibroblastic tumours Myofibroblastic tumour - Intranodal palisaded myofibroblastoma
Spleen-specific vascular-stromal tumours Splenic vascular-stromal tumours - Littoral cell angioma - Splenic hamartoma - Sclerosing angiomatoid nodular transformation (SANT) of spleen
Genetic tumour syndromes (Overview Page Link)
- Fanconi anaemia - Bloom syndrome - Ataxia-telangiectasia syndrome - RASopathies